Drug recall
Prempro (conjugated estrogens/medroxyprogesterone acetate tablets) 0.625 mg/2.5 mg, Rx only, Distributed by…
FDA recall event 59851 · Class III · Pfizer Inc.
Key facts
| Event ID | 59851 |
|---|---|
| Recall numbers | D-719-2012 |
| Recalling firm | Pfizer Inc. |
| Product type | Drugs |
| Products | Prempro (conjugated estrogens/medroxyprogesterone acetate tablets) 0.625 mg/2.5 mg, Rx only, Distributed by Wyeth Pharmaceuticals Inc, A subsidiary of Pfizer Inc. Philadelphia PA 19101 NDC… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Labeling: Label w/Wrong or Incorrect EXP. Date:Expiration date assigned December 2013 instead of December 2012. |
| Initiation date | Aug 29, 2011 |
| Termination date | Sep 24, 2013 |
| City | New York |
| State | NY |
| Country | United States |
| FEI number | 2416101 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports